Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug-Resistant Epilepsy: A Double-Blind Placebo-Controlled Trial.
- 2026-03-01
- RCT · n = 60
- Pharmacotherapy 46(3)
- Amira R Rashdan
- Sahar M El-Haggar
- Ahmed Mustafa Kishk
- Tarek M Mostafa
- PubMed: 41693686
- DOI: 10.1002/phar.70117
- High evidence
- Clinical
a significant improvement in the QOLCE-55 total score (p < 0.0001)
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes
- Dose
- daily probiotic (Lactobacillus acidophilus) supplement